Agency Information Collection Activities: Submission for OMB Review; Comment Request, 12122-12123 [2011-4577]
Download as PDF
12122
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–4944 Filed 3–3–11; 8:45 am]
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2011–4994 Filed 3–3–11; 8:45 am]
[Document Identifier CMS–102 and CMS–
105, and CMS–10241]
Dated: February 25, 2011.
Thelma Sims,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jlentini on DSKJ8SOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of
aforementioned subcommittee:
Time and Date: 8:30 a.m.–11:30 a.m.,
March 21, 2011.
Place: Emory Conference Center Hotel,
1615 Clifton Road, NE., Atlanta, Georgia
30329, Telephone: (404) 712–6000.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people. The
public is welcome to participate during the
public comment periods. The public
comment period is tentatively scheduled for
11 a.m.–11:15 a.m.
Purpose: As a subcommittee to the CDC’s
Advisory Committee to the Director (ACD),
the NBAS will provide counsel to the CDC
and the Federal government through the ACD
regarding a broad range of human health
surveillance issues arising from the
development and implementation of a
roadmap for the human health component of
a national biosurveillance system.
Matters to be Discussed: Agenda items will
include the subcommittee’s discussion,
deliberation, and vote on the proposed report
for enhancing the nation’s biosurveillance
capability.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Pamela Diaz, M.D., Designated Federal
Officer, ACD, CDC—NBAS, 1600 Clifton
Road, NE., M/S E–97, Atlanta, Georgia 30333.
Telephone: (404) 498–0476. E-mail:
pdiaz@cdc.gov. For security reasons,
members of the public interested in attending
the meeting should contact Mark Byers,
Telephone: (404) 498–0481, E-mail:
mbyers@cdc.gov. The deadline for
notification of attendance is March 10, 2011.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
19:16 Mar 03, 2011
Jkt 223001
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Clinical
Laboratory Improvement Amendments
of 1988 (CLIA) Budget Workload
Reports and Supporting Regulations in
42 CFR 493.1–.2001; Use: The collected
information will be used by CMS to
determine the amount of Federal
reimbursement for surveys conducted.
Use of the information includes program
evaluation, audit, budget formulation
and budget approval. Form CMS–102 is
a multi-purpose form designed to
capture and record all budget and
expenditure data. Form CMS–105
captures the annual projected CLIA
workload that the State survey agency
will accomplish. It is also used by the
CMS regional office to approve the
annual projected CLIA workload. The
information is required as part of the
section 1864 agreement with the State;
Form Numbers: CMS–102 and CMS–105
(OMB#: 0938–0599); Frequency:
Quarterly; Affected Public: State, Local,
or Tribal Governments; Number of
Respondents: 50; Total Annual
Responses: 50; Total Annual Hours:
4,500. (For policy questions regarding
AGENCY:
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—National Biosurveillance
Advisory Sbcommittee (NBAS)
VerDate Mar<15>2010
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): The
Association of Genetic Biomarkers and
Hereditary Hemochromatosis, DD11–
008, Initial Review
Correction: This notice was published
in the Federal Register on January 21,
2011, Volume 76, Number 14, Page
3908. The date for the aforementioned
meeting has been changed to the
following:
April 26, 2011 (Closed)
Contact Person for More Information:
Michael Dalmat, Dr.P.H., Scientific
Review Officer, CDC, National Center
for Chronic Disease Prevention and
Health Promotion, Office of the Director,
Extramural Research Program Office,
4770 Buford Highway, NE., Mailstop
K–92, Atlanta, Georgia 30341,
Telephone: (770) 488–6423, E-mail:
MED1@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DATES:
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–4990 Filed 3–3–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\04MRN1.SGM
04MRN1
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
this collection contact Carla Ausby at
410–786–2153. For all other issues call
410–786–1326.)
2. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Annual State
Report and Annual State Performance
Rankings; Use: Section 6001(f) of the
Deficit Reduction Act (DRA) requires
CMS to contract with a vendor to
conduct a monthly national survey of
retail prescription drug prices and to
report the prices to the States. These
national average prices may be used as
a benchmark by the States for the
management of their prescription drug
programs. The DRA also requires that
the States submit pricing information
for the 50 most widely prescribed drugs
so that the States’ prices can be
compared to the national average prices
obtained from the survey. The States
pricing information will be compared
and the States will be ranked. The Act
also requires that States report their
drug utilization rates for noninnovator
multiple source (generic) drugs, their
payment rates under their State plan,
and their dispensing fees. The template
has been developed to facilitate data
collection; Form Number: CMS–10241
(OMB#: 0938–1041); Frequency: Yearly;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
51; Total Annual Responses: 51; Total
Annual Hours: 765. (For policy
questions regarding this collection
contact Joseph Fine at 410–786–2128.
For all other issues call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on April 14, 2011.
OMB, Office of Information and
Regulatory Affairs, Attention: CMS
Desk Officer, Fax Number: (202) 395–
6974, E-mail:
OIRA_submission@omb.eop.gov.
VerDate Mar<15>2010
19:16 Mar 03, 2011
Jkt 223001
Dated: February 23, 2011.
Martique Jones,
Director, Regulations Development Group,
Division B, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2011–4577 Filed 3–3–11; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Blood & Marrow Transplant Network Review
Meeting.
Date: March 28–29, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: ‘‘Courtyard’’ Crystal City—Marriott,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Keith A. Mintzer, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7186,
Bethesda, MD 20892–7924, 301–435–0280,
mintzerk@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pediatric Heart Network Clinical Centers.
Date: March 28–29, 2011.
Time: 1 p.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7178, Bethesda, MD 20892–7924, 301–435–
0725, johnsonwj@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Conference Grant Review.
Date: March 29–30, 2011.
Time: 8 a.m. to 1 p.m.
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
12123
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Dana Phares, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7179, Bethesda, MD 20892–7924, 301–435–
0310, pharesda@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: February 28, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–4943 Filed 3–3–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
Clinical Research.
Date: March 22, 2011.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health/NCRR/
OR, Democracy I, 6701 Democracy Blvd.,
1078, Bethesda, MD (Virtual Meeting).
Contact Person: Steven Birken, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., 10th FL., Bethesda, MD
20892, (301) 435–1078,
birkens@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
E:\FR\FM\04MRN1.SGM
04MRN1
Agencies
[Federal Register Volume 76, Number 43 (Friday, March 4, 2011)]
[Notices]
[Pages 12122-12123]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4577]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-102 and CMS-105, and CMS-10241]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the Agency's function; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
1. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Clinical Laboratory Improvement Amendments of 1988 (CLIA) Budget
Workload Reports and Supporting Regulations in 42 CFR 493.1-.2001; Use:
The collected information will be used by CMS to determine the amount
of Federal reimbursement for surveys conducted. Use of the information
includes program evaluation, audit, budget formulation and budget
approval. Form CMS-102 is a multi-purpose form designed to capture and
record all budget and expenditure data. Form CMS-105 captures the
annual projected CLIA workload that the State survey agency will
accomplish. It is also used by the CMS regional office to approve the
annual projected CLIA workload. The information is required as part of
the section 1864 agreement with the State; Form Numbers: CMS-102 and
CMS-105 (OMB: 0938-0599); Frequency: Quarterly; Affected
Public: State, Local, or Tribal Governments; Number of Respondents: 50;
Total Annual Responses: 50; Total Annual Hours: 4,500. (For policy
questions regarding
[[Page 12123]]
this collection contact Carla Ausby at 410-786-2153. For all other
issues call 410-786-1326.)
2. Type of Information Collection Request: Extension without change
of a currently approved collection; Title of Information Collection:
Annual State Report and Annual State Performance Rankings; Use: Section
6001(f) of the Deficit Reduction Act (DRA) requires CMS to contract
with a vendor to conduct a monthly national survey of retail
prescription drug prices and to report the prices to the States. These
national average prices may be used as a benchmark by the States for
the management of their prescription drug programs. The DRA also
requires that the States submit pricing information for the 50 most
widely prescribed drugs so that the States' prices can be compared to
the national average prices obtained from the survey. The States
pricing information will be compared and the States will be ranked. The
Act also requires that States report their drug utilization rates for
noninnovator multiple source (generic) drugs, their payment rates under
their State plan, and their dispensing fees. The template has been
developed to facilitate data collection; Form Number: CMS-10241
(OMB: 0938-1041); Frequency: Yearly; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 51; Total Annual
Responses: 51; Total Annual Hours: 765. (For policy questions regarding
this collection contact Joseph Fine at 410-786-2128. For all other
issues call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS Web
Site address at https://www.cms.hhs.gov/PaperworkReductionActof1995, or
e-mail your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received by the OMB desk
officer at the address below, no later than 5 p.m. on April 14, 2011.
OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-6974, E-mail: OIRA_submission@omb.eop.gov.
Dated: February 23, 2011.
Martique Jones,
Director, Regulations Development Group, Division B, Office of
Strategic Operations and Regulatory Affairs.
[FR Doc. 2011-4577 Filed 3-3-11; 8:45 am]
BILLING CODE 4120-01-P